The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032

North America held the largest therapeutic proteins market share.

The global therapeutic proteins market is expected to grow from $112.17 billion in 2022 to $125.74 billion in 2023 at a compound annual growth rate (CAGR) of 12.1%. The therapeutic proteins market is expected to grow from $200.43 billion in 2027 at a CAGR of 12.4%.

Major Driver In The Therapeutic Proteins Market ­– Increase In Number Of Biosimilar Drugs
Amneal Pharmaceuticals, Inc., a US-based generics and speciality pharmaceutical firm, for example, introduced ALYMSYS® (bevacizumab-maly) in the United States in October 2022. These low-cost medicines, like the first biologics, reduce revenue and sales of therapeutic proteins.

View More On The Therapeutic Proteins Market Report 2023 – https://www.thebusinessresearchcompany.com/report/therapeutic-proteins-global-market-report

Key Therapeutic Proteins Market Segments
1) By Product Type: Insulin, Fusion Protein, Erythropoietin, Interferon, Human Growth Hormone, Follicle Stimulating Hormone
2) By Application: Metabolic Disorders, Immunologic Disorders, Hematological Disorders, Cancer, Hormonal Disorders, Genetic Disorders, Other Applications
3) By Function: Enzymatic and Regulatory Activity, Special Targeting Activity, Vaccines, Protein Diagnostics

Recent Therapeutic Proteins Market Trend – Adopting Monoclonal Antibody Drug Approvals
Monoclonal antibodies are effective in treating chronic diseases such as cancer and immune disorders. Monoclonal antibodies, which are more safe and immunogenic than antibodies, are a prominent and well-established product class in the protein therapy market. Cell-based expression systems, such as the Chinese hamster ovary (CHO) mammalian cell expression system, have enhanced the production of monoclonal antibodies by addressing the issues associated with earlier antibody medicines.The FDA has authorised 213 medications in the last five years, 44 of which are monoclonal antibodies. For example, the FDA has approved twelve monoclonal antibodies for the treatment of cancer and immunological disorders.

Therapeutic Proteins Market Prominent Players
Major players in the therapeutic proteins market are Abbott Laboratories, Amgen Inc., Baxter International Inc., Eli Lilly and Company, F. Hoffmann-La Roche Ltd., Pfizer Inc., Johnson & Johnson, and Merck & Co. Inc., Novo Nordisk A/S, and Sanofi.

Request A Sample Of The Global Therapeutic Proteins Market Report 2023:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2555&type=smp

The Therapeutic Proteins Global Market Report 2023  provides a comprehensive overview on the therapeutic proteins market size, trends and drivers, opportunities, strategies, and companies analysis. The countries covered in the therapeutic proteins market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA, and the major seven regions are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

Therapeutic proteins are medications that are genetically engineered versions of naturally occurring human proteins. These potent, fast-acting drugs were created in a laboratory for pharmaceutical use. Because therapeutic proteins are particularly successful in vivo, they have changed how diseases are treated.

View More Related Reports –
Therapeutic Dental Equipment Global Market Report 2023
Therapeutic BCG Vaccines Global Market Report 2023
Therapeutic Nutrients And Minerals Global Market Report 2023

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]

Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model